Literature DB >> 23108003

Back pain among long-term survivors of childhood leukemia.

Daniel C Bowers1, Terri Griffith, Lynn Gargan, Cindy J Cochran, Beverly Kleiber, Aleksandra Foxwell, Alan Farrow-Gillespie, Angela Orlino, Julie N Germann.   

Abstract

BACKGROUND: The objectives of this study are to determine the prevalence and relative risk (RR) of back pain and identify possible mechanisms of back pain among childhood acute lymphoblastic leukemia (ALL) survivors.
METHODS: Surveys were mailed to 5 + -year survivors of childhood ALL aged 13 to 25 years. Survivors' siblings were also invited to participate in the study. Prevalence of back pain and hip pain among ALL survivors was determined and compared with siblings. Sex, treatment with radiation therapy, obesity, and physical activity were examined for an association with back pain and hip pain.
RESULTS: Forty-four of 99 (44.4%) ALL survivors reported back pain compared with 11 of 52 (21.2%) their siblings (P = 0.007; RR: 2.01; 95% confidence interval = 1.15-3.56). In contrast, 10 of 99 (10.1%) ALL survivors reported experiencing hip pain compared with 1 of 52 (2.0%) siblings experiencing hip pain [P = 0.07; RR: 4.95 (0.65 to 37.57)]. Twenty-six of 43 female survivors reported back pain compared with 18 of 56 male survivors who reported back pain (P = 0.005). Obesity, physical activity, and treatment with radiation therapy were not associated with back pain or hip pain.
CONCLUSIONS: This is the first study demonstrating an increased frequency of back pain among survivors of childhood ALL. Future studies are needed to better define the causes of back pain among childhood ALL survivors.

Entities:  

Mesh:

Year:  2012        PMID: 23108003     DOI: 10.1097/MPH.0b013e31827080de

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  5 in total

1.  Neurologic morbidity and quality of life in survivors of childhood acute lymphoblastic leukemia: a prospective cross-sectional study.

Authors:  Raja B Khan; Melissa M Hudson; Davonna S Ledet; E Brannon Morris; Ching-Hon Pui; Scott C Howard; Kevin R Krull; Pamela S Hinds; Debbie Crom; Emily Browne; Liang Zhu; Shesh Rai; Deokumar Srivastava; Kirsten K Ness
Journal:  J Cancer Surviv       Date:  2014-07-10       Impact factor: 4.442

2.  Longitudinal pain and pain interference in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.

Authors:  Cynthia W Karlson; Nicole M Alberts; Wei Liu; Tara M Brinkman; Robert D Annett; Daniel A Mulrooney; Fiona Schulte; Wendy M Leisenring; Todd M Gibson; Rebecca M Howell; Deokumar Srivastava; Kevin C Oeffinger; Leslie L Robison; Gregory T Armstrong; Lonnie K Zeltzer; Kevin R Krull
Journal:  Cancer       Date:  2020-03-30       Impact factor: 6.860

Review 3.  Pain Management in Childhood Leukemia: Diagnosis and Available Analgesic Treatments.

Authors:  Flaminia Coluzzi; Monica Rocco; Rula Green Gladden; Pietro Persiani; Laurel A Thur; Filippo Milano
Journal:  Cancers (Basel)       Date:  2020-12-07       Impact factor: 6.639

4.  Effect of Temporal Changes in Therapeutic Exposure on Self-reported Health Status in Childhood Cancer Survivors.

Authors:  Kirsten K Ness; Melissa M Hudson; Kendra E Jones; Wendy Leisenring; Yutaka Yasui; Yan Chen; Marilyn Stovall; Todd M Gibson; Daniel M Green; Joseph P Neglia; Tara O Henderson; Jacqueline Casillas; Jennifer S Ford; Karen E Effinger; Kevin R Krull; Gregory T Armstrong; Leslie L Robison; Kevin C Oeffinger; Paul C Nathan
Journal:  Ann Intern Med       Date:  2016-11-08       Impact factor: 25.391

5.  Pain in long-term survivors of childhood cancer: A systematic review of the current state of knowledge and a call to action from the Children's Oncology Group.

Authors:  Fiona S M Schulte; Michaela Patton; Nicole M Alberts; Alicia Kunin-Batson; Barbara A Olson-Bullis; Caitlin Forbes; K Brooke Russell; Alexandra Neville; Lauren C Heathcote; Cynthia W Karlson; Nicole M Racine; Courtney Charnock; Matthew C Hocking; Pia Banerjee; Perri R Tutelman; Melanie Noel; Kevin R Krull
Journal:  Cancer       Date:  2020-10-28       Impact factor: 6.860

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.